Investment analysts at Zacks Research increased their Q1 2025 earnings estimates for shares of UnitedHealth Group in a report released on Thursday, March 6th. Zacks Research analyst D. Chatterjee now ...

UnitedHealth Group ... estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings ...

UnitedHealth Group ... estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings ...

UnitedHealth Group reported bottom-line earnings that surpassed estimates despite regulatory ... as they will shape future performance. With evolving market dynamics, including Medicare rate ...

Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) have been assigned an average rating of “Buy” from the ...

UnitedHealth Group, Inc. engages in the provision of health ... The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care ...

UnitedHealth Group ... earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future.

As of 2025-02-03, UnitedHealth Group Inc's intrinsic value as calculated by the Discounted Earnings model is $736.04. It's currently trading at a price of $542.49. Therefore, the margin of safety ...

UnitedHealth Group (UNH) stock is down more than 9% in ... which is offsetting a third-quarter earnings beat. Track all markets on TradingView In the three months ended September 30 ...

UnitedHealth Group (UNH ... value of its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock are ...

UnitedHealth ... or bleak future. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects.